Study guide / Measured changes and risks
What did tesamorelin research measure in people?
Studies measured belly fat, liver fat, IGF-1 blood changes, and side effects. Most people in them were living with HIV.
What did the main tesamorelin studies find?
All people behind the three chief results had HIV. The studies didn't test ordinary weight loss.
One trial found 15.2% less deep belly fat. Blood IGF-1 rose 81%; the liver makes this growth protein.
Another trial found 37% less liver fat. Those changes aren't proved for other people.
Tesamorelin prompts the small growth gland. Growth hormone comes next.
The drug doesn't contain growth hormone itself. The IGF-1 rise still brings cancer and pregnancy warnings.
What does tesamorelin mechanism of action mean for IGF-1?
Mechanism of action means the body steps started by a drug. Tesamorelin first reaches a small gland just beneath the brain.
The drug locks onto the outside of certain gland cells [4]. That touch makes the cells send growth hormone.
Growth hormone arrives in brief waves. The liver then makes IGF-1, a growth protein found by blood tests.
IGF-1 joins growth hormone in reducing deep belly fat [1]. They don't act like a simple calorie burner.
One added piece protects tesamorelin from a cutting enzyme [4]. Enzymes are proteins that perform work inside the body.
Tesamorelin still leaves blood fairly fast. The body's own hormone reply lasts longer.
One study found the expected short hormone bursts [15]. The later IGF-1 rise continued after tesamorelin was gone.
What did tesamorelin do in healthy men?
The growth gland released hormone in short bursts after tesamorelin [4]. The liver then made more IGF-1, its growth protein.
Only 13 healthy men joined this small study. They received tesamorelin 2 mg/day for two weeks.
IGF-1 rose 181 micrograms per liter. Growth hormone also rose overnight [4].
The report gives no normal range here. These blood changes can't prove weight loss or safety for everyone.
Does tesamorelin contain growth hormone?
No, tesamorelin isn't growth hormone. Your own supply comes from the growth gland after the drug acts.
Healthy men had more growth hormone overnight. IGF-1, their liver-made growth protein, rose 181 micrograms per liter over two weeks [4].
How does tesamorelin start growth hormone release?
Tesamorelin locks onto growth-gland cells. Those cells put growth hormone into the bloodstream [4].
The hormone arrives in brief waves, not a steady stream. One added piece shields tesamorelin from quick breakdown [4].
Does tesamorelin raise IGF-1 in blood?
Yes. The biggest HIV study found an 81.0% rise in IGF-1, a liver-made growth protein [1].
In healthy men, IGF-1 rose 181 micrograms per liter over two weeks [4]. The increase helps explain both fat loss and the cancer warning [5].
Which tesamorelin benefits did trials measure?
Everyone behind these results had HIV. The findings don't show what happens in all other people.
In the main 26-week trial, deep belly fat fell 15.2%. It rose 5.0% with placebo instead [1].
Blood fat fell 50 milligrams per deciliter. IGF-1, the liver-made growth protein, rose 81.0%.
At 52 weeks, deep fat remained 18% below the start [2]. That result depended on continued care.
A 6-month study followed 50 adults taking HIV drugs. One belly-scan area fell 42 square centimeters more than with placebo [3].
Liver fat also fell 2.9% more. Both fat measures moved the same way.
Another scan found the remaining fat looked denser [7]. There, denser meant healthier-looking fat, not more fat.
A clot-linked blood sign fell. A hormone that helps insulin handle sugar rose a little [9].
Those blood changes came with less belly fat. The fat loss itself may have caused them.
How long did the changes last, and for whom?
Two limits come before the favorable results. Belly fat began returning within weeks after tesamorelin stopped [2].
The 52-week work found less fat during treatment. It also found the loss reversed after treatment ended [2].
The main studies enrolled adults taking HIV drugs [1][2][3]. They weren't broad weight-loss studies.
A 2024 trial used newer HIV medicines. One belly-scan area fell 25 square centimeters while placebo rose 14 square centimeters [10].
That scan measured one cross-section of the belly. The newer work still covered only people with HIV.
A separate blood sugar study found no clear change. Studies of thinking skills gave mixed results.
A 2026 review found no solid basis for bone or joint care [11]. Proposed care for sore joints remains unproved.
The fat changes held up in the people studied. Their narrow reach matters for your decision.
Which tesamorelin side effects did trials find?
Most recorded tesamorelin side effects were mild. A major review found no known liver injury [5].
The shot area could become sore or red. Blood sugar changes stayed small over 52 weeks [2].
The body may also hold extra water. Growth hormone and IGF-1, the liver-made growth protein, can cause that [2].
Active cancer bars tesamorelin because IGF-1 can spur growth. A known drug allergy and pregnancy also bar it [5].
Deep belly fat returns after treatment ends [2]. The IGF-1 effect therefore is not a one-time fix.
Tesamorelin's growth-hormone effect bars it from organized sport. These facts can't replace a review of your health.
What are tesamorelin side effects, in brief?
A major review found no known liver harm from the drug [5]. Trials found shot-area soreness and small blood sugar changes [2].
Active cancer bars the drug because IGF-1 may spur growth [5]. A known allergy and pregnancy also bar it.